← Leaderboards
Edward Belongia
Marshfield Clinic Research Foundation
$21,060,891
Attributed
$21,060,891
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
CDC$21,060,891 · 5
By mechanism
U01$16,182,086 · 4
U18$4,878,805 · 1
Top collaborators
No co-investigators on record.
Most similar at Marshfield Clinic Research Foundation
Same institution · by research overlap
- Sanjay K Shukla$3,338,521
- Huong Q Nguyen$3,050,000
Others in their field
Top investigators on “Medical Outreach /Case Finding”
- Gregory H Reaman · National Childhood Cancer Foundation$123,104,101
- Norman Wolmark · Nsabp Foundation, Inc.$67,244,416
- Jeffrey P Krischer · University Of South Florida$38,040,597
- Craig M Wilson · University Of Alabama At Birmingham$18,996,867
- W. Archie Bleyer · National Childhood Cancer Foundation$18,804,557
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$16,145,568
Research focus
Medical Outreach /Case FindingDisease /Disorder Proneness /RiskChronic Disease /DisorderDrug Screening /EvaluationHuman SubjectInfluenzaInfluenza VaccinesMicroorganism CultureRespiratory Disorder EpidemiologyAge DifferenceSample CollectionClinical ResearchCooperative StudyDisease Outbreaks
Grant awards (22)
Annual Estimates of Influenza Vaccine Effectiveness and Evaluation of Immune Response in a Wisconsin Population$1,800,000
U01 · FY2020 · IP · contact PI
Annual Estimates of Influenza Vaccine Effectiveness and Evaluation of Immune Response in a Wisconsin Population$1,900,000
U01 · FY2019 · IP · contact PI
Annual Estimates of Influenza Vaccine Effectiveness and Evaluation of Immune Response in a Wisconsin Population$500,000
U01 · FY2019 · IP · contact PI
Annual Estimates of Influenza Vaccine Effectiveness and Evaluation of Immune Response in a Wisconsin Population$1,600,000
U01 · FY2018 · IP · contact PI
Annual Estimates of Influenza Vaccine Effectiveness and Evaluation of Immune Response in a Wisconsin Population$1,100,000
U01 · FY2017 · IP · contact PI
Annual Estimates of Influenza Vaccine Effectiveness and Evaluation of Immune Response in a Wisconsin Population$1,100,000
U01 · FY2016 · IP · contact PI
Core_plus Option_B_C_Influenza Vaccine Effectiveness in a Wisconsin Population$1,107,551
U01 · FY2015 · IP · contact PI
Core_plus Option_B_C_Influenza Vaccine Effectiveness in a Wisconsin Population$1,245,000
U01 · FY2014 · IP · contact PI
Core_plus Option_B_C_Influenza Vaccine Effectiveness in a Wisconsin Population$1,085,000
U01 · FY2013 · IP · contact PI
Core_plus Option_B_C_Influenza Vaccine Effectiveness in a Wisconsin Population$1,085,000
U01 · FY2012 · IP · contact PI
Core_plus Option_B_C_Influenza Vaccine Effectiveness in a Wisconsin Population$1,085,000
U01 · FY2011 · IP · contact PI
Rapid Estimation of Influenza Vaccine Effectiveness in a Wisconsin Population Coh$1,350,000
U18 · FY2010 · IP · contact PI
Rapid Estimation of Influenza Vaccine Effectiveness in a Wisconsin Population Coh$946,209
U18 · FY2010 · IP · contact PI
Clinical Trial of Oseltamivir Efficacy for Reducing Influenza Severity$250,000
U01 · FY2010 · IP · contact PI
Rapid Estimation of Influenza Vaccine Effectiveness in a Wisconsin Population Coh$1,623,642
U18 · FY2009 · IP · contact PI
Rapid Estimation of Influenza Vaccine Effectiveness in a Wisconsin Population Coh$958,954
U18 · FY2008 · IP · contact PI
Clinical Trial of Oseltamivir Efficacy for Reducing Influenza Severity$1,277,517
U01 · FY2007 · IP · contact PI
Rapid Analysis of Influenza Vaccine Effectiveness$500,000
U01 · FY2007 · CI · contact PI
Rapid Analysis of Influenza Vaccine Effectiveness$500,000
U01 · FY2006 · CI · contact PI
Rapid Analysis of Influenza Vaccine Effectiveness$47,018
U01 · FY2006 · CI · contact PI
Rapid Analysis of Influenza Vaccine Effectiveness$0
U01 · FY2005 · CI
Rapid Analysis of Influenza Vaccine Effectiveness$0
U01 · FY2004 · CI